A Contract Research Organization (CRO) and a wholly-owned subsidiary of Wellbeing Digital Sciences Inc. (OTC: KONEF), KGK Science’s application for a Controlled Drugs And Substances (CDS) dealers license with Health Canada has been approved to proceed with the buildout of a level 5 security system at its research facility in London, Ontario. 

See also: Adastra Clarifies Health Canada Approval To Handle Cocaine

After being completed and inspected this spring, KGK expects to receive the license which will allow the company to lawfully possess, import, sell and study several controlled substances including psilocybin, LSD, …

Full story available on Benzinga.com